CTBP2P8: A Potential Drug Target and Biomarker (G100420253)

Target Name: CTBP2P8

NCBI ID: G100420253

CTBP2P8

Other Name(s): CTBP2 pseudogene 8

CTBP2P8: A Potential Drug Target and Biomarker

CTBP2P8, also known as CTBP2, is a protein that is expressed in various tissues and organs, including the brain, heart, and kidneys. It is a member of the CTBP family, which includes several related proteins that play a critical role in cell-cell adhesion and signaling. One of the most interesting aspects of CTBP2P8 is its potential as a drug target and biomarker.

The CTBP2P8 protein is known for its role in the development and maintenance of blood-brain barrier (BBB) integrity. The BBB is a barrier that separates the brain from the surrounding bloodstream, and it is critical for the proper functioning of the brain. However, the BBB can be easily bypassed by certain diseases, such as cancer, which can lead to the spread of the disease to the brain.

Research has shown that CTBP2P8 plays a critical role in the regulation of the BBB. It is involved in the formation of tight junctions, which are a type of cell-cell adhesion that helps to maintain the integrity of the BBB. Additionally, CTBP2P8 is involved in the degradation of other proteins that can affect BBB function, such as the transmembrane protein known as Zonin.

As a drug target, CTBP2P8 is an attractive target for researchers because of its involvement in the regulation of the BBB. By targeting this protein, researchers can potentially develop new treatments for diseases that are characterized by BBB dysfunction, such as cancer. Additionally, CTBP2P8 may also be a useful biomarker for tracking the effectiveness of certain treatments.

In addition to its potential as a drug target, CTBP2P8 has also been shown to be a valuable biomarker for certain diseases. For example, studies have shown that elevated levels of CTBP2P8 have been associated with the development of certain types of cancer, such as lung and ovarian cancer. Additionally, research has also shown that lowering CTBP2P8 levels can be an effective way to inhibit the growth of certain types of cancer cells.

Overall, CTBP2P8 is a protein that has the potential to be a drug target and biomarker. Its involvement in the regulation of the BBB and its association with the development of certain types of cancer make it an attractive target for researchers. Additionally, its potential as a biomarker makes it an important tool for tracking the effectiveness of certain treatments.

While more research is needed to fully understand the role of CTBP2P8 in the regulation of the BBB and its potential as a drug target and biomarker, its potential impact on cancer research and treatment is significant. As research continues to advance, the role of CTBP2P8 in the regulation of the BBB and its potential as a drug target and biomarker will become increasingly important for the development of new treatments for a wide range of diseases.

Protein Name: CTBP2 Pseudogene 8

The "CTBP2P8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CTBP2P8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets